Cite
MLA Citation
Balaji Ramachandran et al.. “Repeated dose studies with pure Epigallocatechin-3-gallate demonstrated dose and route dependant hepatotoxicity with associated dyslipidemia.” Toxicology reports, vol. 3, 2016, pp. 336–345. http://access.bl.uk/ark:/81055/vdc_100039476208.0x000021